Overview

The Effect of Aliskiren on Endothelial Function in Pre-Diabetes and Diabetes

Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The purpose of this research is to study and determine the effects of Aliskiren on blood vessels and blood flow. The primary hypothesis is that Aliskiren will increase endothelial function by 30% or more in comparison to the placebo group.
Phase:
N/A
Details
Lead Sponsor:
Beth Israel Deaconess Medical Center
Collaborator:
Novartis Pharmaceuticals